LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 613

Search options

  1. Book ; Online ; E-Book: Hepatitis B virus and liver disease

    Kao, Jia-Horng

    2021  

    Author's details Jia-Horng Kao, editor
    Keywords Hepatitis B virus ; Virus de l'hepatitis B ; Malalties del fetge
    Subject code 616.3623
    Language English
    Size 1 online resource (507 pages)
    Edition 2nd ed.
    Publisher Springer
    Publishing place Gateway East, Singapore
    Document type Book ; Online ; E-Book
    Note Includes index.
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    ISBN 981-16-3615-X ; 981-16-3614-1 ; 978-981-16-3615-8 ; 978-981-16-3614-1
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Book: Hepatitis B Virus and Liver Disease

    Kao, Jia-Horng

    2021  

    Author's details Jia-Horng Kao Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan§
    Keywords Hepatocellular carcinoma ; HBV ; Chronic Hepatitis ; liver cirrhosis ; Immunosuppressive therapy ; Immunopathogenesis ; hepatocellular carcinoma ; hepatitis B virus ; chronic hepatitis ; immunosuppressive therapy
    Language English
    Size 520 p.
    Edition 2
    Publisher Springer Nature Singapore
    Document type Book
    Note PDA Manuell_11
    Format 160 x 241 x 26
    ISBN 9789811636141 ; 9811636141
    Database PDA

    Kategorien

  3. Book ; Online ; E-Book: Artificial Intelligence, Machine Learning, and Deep Learning in Precision Medicine in Liver Diseases

    Su, Tung-Hung / Kao, Jia-Horng

    Concept, Technology, Application and Perspectives

    2023  

    Subject code 616.36206028563
    Language English
    Size 1 online resource (352 pages)
    Edition 1st ed.
    Publisher Elsevier Science & Technology
    Publishing place San Diego
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    ISBN 0-323-99376-1 ; 9780323991360 ; 978-0-323-99376-0 ; 032399136X
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  4. Book: NOhep: toward global control of hepatitis B virus infection

    Kao, Jia-Horng

    (The journal of infectious diseases ; volume 216, supplement 8 (15 October 2017))

    2017  

    Author's details editors: Jia-Horng Kao MD, PhD, FAASLD; Chun-Jen Liu MD, PhD
    Series title The journal of infectious diseases ; volume 216, supplement 8 (15 October 2017)
    Collection
    Language English
    Size Seite S749-S796
    Publisher Oxford University Press
    Publishing place Cary, NC
    Publishing country United States
    Document type Book
    HBZ-ID HT019602462
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  5. Book ; Online ; E-Book: Hepatitis B Virus and liver disease

    Kao, Jia-Horng / Chen, Ding-Shinn

    2018  

    Author's details Jia-Horng Kao, Ding-Shinn Chen editors
    Keywords Medicine ; Virology ; Hepatology ; Infectious diseases
    Subject code 616.36
    Language English
    Size 1 Online-Ressource (xvii, 360 Seiten), Illustrationen
    Publisher Springer
    Publishing place Singapore
    Publishing country Singapore
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT019616510
    ISBN 978-981-10-4843-2 ; 9789811048425 ; 981-10-4843-6 ; 9811048428
    DOI 10.1007/978-981-10-4843-2
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  6. Article: Role of artificial intelligence in the management of chronic hepatitis B infection.

    Su, Tung-Hung / Kao, Jia-Horng

    Clinical liver disease

    2024  Volume 23, Issue 1, Page(s) e0164

    Language English
    Publishing date 2024-05-03
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2657644-2
    ISSN 2046-2484
    ISSN 2046-2484
    DOI 10.1097/CLD.0000000000000164
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Highlights.

    Kao, Jia-Horng

    Journal of the Formosan Medical Association = Taiwan yi zhi

    2021  Volume 120, Issue 6, Page(s) 1289–1292

    Language English
    Publishing date 2021-01-27
    Publishing country Singapore
    Document type Editorial
    ZDB-ID 2096659-3
    ISSN 1876-0821 ; 0929-6646
    ISSN (online) 1876-0821
    ISSN 0929-6646
    DOI 10.1016/j.jfma.2021.05.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: New Approaches to Chronic Hepatitis B.

    Tseng, Tai-Chung / Kao, Jia-Horng

    The New England journal of medicine

    2023  Volume 388, Issue 12, Page(s) 1148

    MeSH term(s) Humans ; Hepatitis B, Chronic/drug therapy ; Hepatitis B virus ; Antiviral Agents/therapeutic use
    Chemical Substances Antiviral Agents
    Language English
    Publishing date 2023-03-22
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc2301248
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Letter to the Editor: Learning more about the safety of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.

    Wang, Chia-Chi / Kao, Jia-Horng

    Hepatology (Baltimore, Md.)

    2023  Volume 77, Issue 4, Page(s) E82–E83

    MeSH term(s) Humans ; Carcinoma, Hepatocellular/drug therapy ; Bevacizumab/adverse effects ; Liver Neoplasms/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
    Chemical Substances Bevacizumab (2S9ZZM9Q9V) ; atezolizumab (52CMI0WC3Y)
    Language English
    Publishing date 2023-01-03
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1097/HEP.0000000000000009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection.

    Lin, Chih-Lin / Kao, Jia-Horng

    Clinical and molecular hepatology

    2023  Volume 29, Issue 3, Page(s) 605–622

    Abstract: Hepatitis B virus (HBV) is responsible for more than 50% of hepatocellular carcinoma (HCC) in HBV hyperendemic areas, such as the Asia-Pacific region. Several hepatitis B viral factors are involved in HBV-related hepatocarcinogenesis. Hepatitis B viral ... ...

    Abstract Hepatitis B virus (HBV) is responsible for more than 50% of hepatocellular carcinoma (HCC) in HBV hyperendemic areas, such as the Asia-Pacific region. Several hepatitis B viral factors are involved in HBV-related hepatocarcinogenesis. Hepatitis B viral load is the most important risk factor of HCC development. In addition, HBV integration, HBV genotype C, and core-promoter mutations are also associated with a risk of HCC development. For untreated chronic hepatitis B (CHB) patients, the estimated HCC incidence rates per 100 patient-years were 0.03-0.17 in inactive carriers, 0.07-0.42 in asymptomatic carriers, 0.12-0.49 in chronic hepatitis, and 2.03-3.37 in cirrhosis. Complementary to HBV DNA, serum levels of the hepatitis B surface antigen and hepatitis B core-related antigen (HBcrAg) can predict the occurrence of HCC for untreated patients with low and intermediate viral loads, respectively. For patients receiving antiviral therapy, the risks of HCC occurrence 40-60% lower than those for untreated patients. Patients treated with residual detectable HBV DNA or intrahepatic cccDNA still have a risk of HCC. Serum levels of HBcrAg, M2BPGi and fibrosis-4 are predictive of the risk of HCC development in treated patients. Several well-developed HCC risk scores can help clinicians identify high-risk CHB patients for HCC surveillance, regardless of treatment status. These strategies can help minimize the threat of HCC and prolong survival in CHB patients.
    MeSH term(s) Humans ; Carcinoma, Hepatocellular/genetics ; Hepatitis B, Chronic/complications ; Hepatitis B, Chronic/drug therapy ; Liver Neoplasms/epidemiology ; DNA, Viral ; Hepatitis B virus/genetics ; Hepatitis B Core Antigens ; Hepatitis B/complications
    Chemical Substances DNA, Viral ; Hepatitis B Core Antigens
    Language English
    Publishing date 2023-02-15
    Publishing country Korea (South)
    Document type Journal Article ; Review
    ZDB-ID 2672560-5
    ISSN 2287-285X ; 2287-2728
    ISSN (online) 2287-285X
    ISSN 2287-2728
    DOI 10.3350/cmh.2022.0342
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top